Literature DB >> 32827651

Glucose induces metabolic reprogramming in neutrophils during type 2 diabetes to form constitutive extracellular traps and decreased responsiveness to lipopolysaccharides.

Manjunath B Joshi1, Rayees Ahamed2, Mangala Hegde2, Aswathy S Nair2, Lingadakai Ramachandra3, Kapaettu Satyamoorthy2.   

Abstract

Recurrent infections are one of the common morbidities in Type 2 Diabetes (T2D) subjects. Bidirectional activation of innate immune cells such as neutrophils and glucose metabolism in T2D conditions leads to a pro-inflammatory milieu and reduced neutrophil function, which can be a potential cause for recurrent infections. In pathological conditions of sterile inflammation associated T2D, neutrophils form constitutive extracellular traps (NETs) due to hyperglycemia and respond poorly to infections. The present study was aimed at understanding the cellular and metabolic consequences, and NETs formation in T2D. We show that glucose induces NADPH oxidase derived reactive oxygen species and further citrullinates the histones to form weaker NETs leading to reduced response to lipopolysaccharide (LPS). Untargeted metabolomics analysis in neutrophils cultured under high glucose and from T2D subjects revealed enrichment of polyol pathway intermediates (1-anhydrosorbitol) and reduced glutathione metabolism products (cysteinylglycine). NADPH is an absolute requirement for three independent pathways of formation of 1-anhydrosorbitol via aldose reductase under excess glucose, induction of glutathione synthesis and glucose induced NETs formation. During T2D and in presence of high glucose, there is a competition for NADPH between these processive reactions, which leads to its insufficiency to produce NETs in response to LPS. Interestingly, supplementation of NADPH and pharmacological inhibitor of aldose reductase, ranirestat, restored NETs formation in presence of LPS. Our study provides novel insights on the metabolic reprogramming of neutrophils, which may lead to susceptibility of T2D subjects to infections.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Metabolomics; Neutrophil extracellular traps; Type 2 diabetes, LC-MS, inflammation

Mesh:

Substances:

Year:  2020        PMID: 32827651     DOI: 10.1016/j.bbadis.2020.165940

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  6 in total

1.  Role of neutrophils in type 2 diabetes and associated atherosclerosis.

Authors:  W Coles Keeter; Alina K Moriarty; Elena V Galkina
Journal:  Int J Biochem Cell Biol       Date:  2021-10-13       Impact factor: 5.085

Review 2.  The Immune-Centric Revolution in the Diabetic Foot: Monocytes and Lymphocytes Role in Wound Healing and Tissue Regeneration-A Narrative Review.

Authors:  Laura Rehak; Laura Giurato; Marco Meloni; Andrea Panunzi; Giada Maria Manti; Luigi Uccioli
Journal:  J Clin Med       Date:  2022-02-08       Impact factor: 4.241

Review 3.  Emerging role of neutrophil extracellular traps in the complications of diabetes mellitus.

Authors:  Areez Shafqat; Saleha Abdul Rab; Osama Ammar; Sulaiman Al Salameh; Anas Alkhudairi; Junaid Kashir; Khaled Alkattan; Ahmed Yaqinuddin
Journal:  Front Med (Lausanne)       Date:  2022-08-23

Review 4.  Defining the role of neutrophils in the lung during infection: Implications for tuberculosis disease.

Authors:  E Gaffney; D Murphy; A Walsh; S Connolly; S A Basdeo; J Keane; J J Phelan
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

5.  A Potential Synbiotic Strategy for the Prevention of Type 2 Diabetes: Lactobacillus paracasei JY062 and Exopolysaccharide Isolated from Lactobacillus plantarum JY039.

Authors:  Jiayuan Zhao; Lihan Wang; Shasha Cheng; Yu Zhang; Mo Yang; Ruxue Fang; Hongxuan Li; Chaoxin Man; Yujun Jiang
Journal:  Nutrients       Date:  2022-01-16       Impact factor: 5.717

Review 6.  The Gut Microbiota Influenced by the Intake of Probiotics and Functional Foods with Prebiotics Can Sustain Wellness and Alleviate Certain Ailments like Gut-Inflammation and Colon-Cancer.

Authors:  Divakar Dahiya; Poonam Singh Nigam
Journal:  Microorganisms       Date:  2022-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.